Antiepileptic drugs and suicidality

Konstantinos N. Fountoulakis, X. Gonda, Myrto Samara, Marianna Siapera, Vaggelis Karavelas, Dragana I. Ristic, Apostolos Iacovides

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

The current study is a systematic review of the literature concerning the possible relationship of antiepileptics and suicide-related clinical features and behaviours. A MEDLINE search returned 863 papers but only five were chosen as relevant. A critical analysis of the Food and Drug Administration report is also included. Overall, the current review suggests there are no convincing data concerning a 'class effect' of antiepileptics in inducing any type of suicide-related behaviours. Further research is needed concerning topiramate, lamotrigine and maybe leviracetam. Clinicians are expected to inform patients and their families on the possible increased risk but it is important not to overemphasise the issue, since stopping or refusing to start antiepileptics may result in serious harm, including death of the patient. Future randomised controlled trials should specifically focus on issues concerning depression and suicidal thoughts in patients with epilepsy.

Original languageEnglish
Pages (from-to)1401-1407
Number of pages7
JournalJournal of Psychopharmacology
Volume26
Issue number11
DOIs
Publication statusPublished - Nov 2012

Fingerprint

Anticonvulsants
Suicide
United States Food and Drug Administration
MEDLINE
Epilepsy
Randomized Controlled Trials
Depression
Research
topiramate
lamotrigine

Keywords

  • anticonvulsants
  • antiepileptics
  • Suicidality

ASJC Scopus subject areas

  • Pharmacology
  • Pharmacology (medical)
  • Psychiatry and Mental health

Cite this

Fountoulakis, K. N., Gonda, X., Samara, M., Siapera, M., Karavelas, V., Ristic, D. I., & Iacovides, A. (2012). Antiepileptic drugs and suicidality. Journal of Psychopharmacology, 26(11), 1401-1407. https://doi.org/10.1177/0269881112440514

Antiepileptic drugs and suicidality. / Fountoulakis, Konstantinos N.; Gonda, X.; Samara, Myrto; Siapera, Marianna; Karavelas, Vaggelis; Ristic, Dragana I.; Iacovides, Apostolos.

In: Journal of Psychopharmacology, Vol. 26, No. 11, 11.2012, p. 1401-1407.

Research output: Contribution to journalArticle

Fountoulakis, KN, Gonda, X, Samara, M, Siapera, M, Karavelas, V, Ristic, DI & Iacovides, A 2012, 'Antiepileptic drugs and suicidality', Journal of Psychopharmacology, vol. 26, no. 11, pp. 1401-1407. https://doi.org/10.1177/0269881112440514
Fountoulakis KN, Gonda X, Samara M, Siapera M, Karavelas V, Ristic DI et al. Antiepileptic drugs and suicidality. Journal of Psychopharmacology. 2012 Nov;26(11):1401-1407. https://doi.org/10.1177/0269881112440514
Fountoulakis, Konstantinos N. ; Gonda, X. ; Samara, Myrto ; Siapera, Marianna ; Karavelas, Vaggelis ; Ristic, Dragana I. ; Iacovides, Apostolos. / Antiepileptic drugs and suicidality. In: Journal of Psychopharmacology. 2012 ; Vol. 26, No. 11. pp. 1401-1407.
@article{9fbe993af769488f8a907c2e5de2df2a,
title = "Antiepileptic drugs and suicidality",
abstract = "The current study is a systematic review of the literature concerning the possible relationship of antiepileptics and suicide-related clinical features and behaviours. A MEDLINE search returned 863 papers but only five were chosen as relevant. A critical analysis of the Food and Drug Administration report is also included. Overall, the current review suggests there are no convincing data concerning a 'class effect' of antiepileptics in inducing any type of suicide-related behaviours. Further research is needed concerning topiramate, lamotrigine and maybe leviracetam. Clinicians are expected to inform patients and their families on the possible increased risk but it is important not to overemphasise the issue, since stopping or refusing to start antiepileptics may result in serious harm, including death of the patient. Future randomised controlled trials should specifically focus on issues concerning depression and suicidal thoughts in patients with epilepsy.",
keywords = "anticonvulsants, antiepileptics, Suicidality",
author = "Fountoulakis, {Konstantinos N.} and X. Gonda and Myrto Samara and Marianna Siapera and Vaggelis Karavelas and Ristic, {Dragana I.} and Apostolos Iacovides",
year = "2012",
month = "11",
doi = "10.1177/0269881112440514",
language = "English",
volume = "26",
pages = "1401--1407",
journal = "Journal of Psychopharmacology",
issn = "0269-8811",
publisher = "SAGE Publications Ltd",
number = "11",

}

TY - JOUR

T1 - Antiepileptic drugs and suicidality

AU - Fountoulakis, Konstantinos N.

AU - Gonda, X.

AU - Samara, Myrto

AU - Siapera, Marianna

AU - Karavelas, Vaggelis

AU - Ristic, Dragana I.

AU - Iacovides, Apostolos

PY - 2012/11

Y1 - 2012/11

N2 - The current study is a systematic review of the literature concerning the possible relationship of antiepileptics and suicide-related clinical features and behaviours. A MEDLINE search returned 863 papers but only five were chosen as relevant. A critical analysis of the Food and Drug Administration report is also included. Overall, the current review suggests there are no convincing data concerning a 'class effect' of antiepileptics in inducing any type of suicide-related behaviours. Further research is needed concerning topiramate, lamotrigine and maybe leviracetam. Clinicians are expected to inform patients and their families on the possible increased risk but it is important not to overemphasise the issue, since stopping or refusing to start antiepileptics may result in serious harm, including death of the patient. Future randomised controlled trials should specifically focus on issues concerning depression and suicidal thoughts in patients with epilepsy.

AB - The current study is a systematic review of the literature concerning the possible relationship of antiepileptics and suicide-related clinical features and behaviours. A MEDLINE search returned 863 papers but only five were chosen as relevant. A critical analysis of the Food and Drug Administration report is also included. Overall, the current review suggests there are no convincing data concerning a 'class effect' of antiepileptics in inducing any type of suicide-related behaviours. Further research is needed concerning topiramate, lamotrigine and maybe leviracetam. Clinicians are expected to inform patients and their families on the possible increased risk but it is important not to overemphasise the issue, since stopping or refusing to start antiepileptics may result in serious harm, including death of the patient. Future randomised controlled trials should specifically focus on issues concerning depression and suicidal thoughts in patients with epilepsy.

KW - anticonvulsants

KW - antiepileptics

KW - Suicidality

UR - http://www.scopus.com/inward/record.url?scp=84867507090&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84867507090&partnerID=8YFLogxK

U2 - 10.1177/0269881112440514

DO - 10.1177/0269881112440514

M3 - Article

VL - 26

SP - 1401

EP - 1407

JO - Journal of Psychopharmacology

JF - Journal of Psychopharmacology

SN - 0269-8811

IS - 11

ER -